Icosavax Management
Management criteria checks 1/4
Icosavax's CEO is Adam Simpson, appointed in Dec 2017, has a tenure of 6.17 years. total yearly compensation is $6.91M, comprised of 8.4% salary and 91.6% bonuses, including company stock and options. directly owns 2.01% of the company’s shares, worth $15.66M. The average tenure of the management team and the board of directors is 1.9 years and 2.8 years respectively.
Key information
Adam Simpson
Chief executive officer
US$6.9m
Total compensation
| CEO salary percentage | 8.4% |
| CEO tenure | 6.2yrs |
| CEO ownership | 2.0% |
| Management average tenure | 1.9yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth
Jul 04
Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?
Mar 10Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?
Oct 18Icosavax GAAP EPS of -$0.57
Aug 15Icosavax to pursue COVID bivalent vaccine in 2023 as biotech highlights near-term milestones
Jul 28Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation
Jun 22Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation
Mar 24We're Hopeful That Icosavax (NASDAQ:ICVX) Will Use Its Cash Wisely
Oct 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$97m |
| Jun 30 2023 | n/a | n/a | -US$97m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$7m | US$580k | -US$92m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$99m |
| Mar 31 2022 | n/a | n/a | -US$85m |
| Dec 31 2021 | US$18m | US$507k | -US$67m |
| Sep 30 2021 | n/a | n/a | -US$53m |
| Jun 30 2021 | n/a | n/a | -US$25m |
| Mar 31 2021 | n/a | n/a | -US$21m |
| Dec 31 2020 | US$623k | US$357k | -US$19m |
Compensation vs Market: Adam's total compensation ($USD6.91M) is above average for companies of similar size in the US market ($USD3.31M).
Compensation vs Earnings: Adam's compensation has been consistent with company performance over the past year.
CEO
Adam Simpson (47 yo)
6.2yrs
Tenure
US$6,906,391
Compensation
Mr. Adam K. Simpson serves as President, Chief Executive Officer and Director of Icosavax, Inc. since December 2017 and also serves as its Co-Founder. Since 2012, Mr. Simpson has also served as the Preside...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.2yrs | US$6.91m | 2.01% $ 15.7m | |
| Chief Medical Officer | 4.5yrs | US$2.22m | 0.37% $ 2.9m | |
| Treasurer & Chief Business Officer | no data | US$2.38m | 0.20% $ 1.5m | |
| Chair of Scientific Advisory Board & Co-Founder | no data | no data | no data | |
| Co-founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Chief Financial Officer | 2.7yrs | US$5.76m | 0.017% $ 130.2k | |
| Senior Vice President of Technical Operations | 1.1yrs | no data | no data | |
| General Counsel & Corporate Secretary | 2.4yrs | US$7.85m | 0.039% $ 305.4k | |
| Senior Vice President of People & Culture | 1.9yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs | 1.9yrs | no data | no data | |
| Executive VP and Head of R&D | less than a year | no data | no data | |
| Senior Vice President of Preclinical R&D | less than a year | no data | no data |
1.9yrs
Average Tenure
52yo
Average Age
Experienced Management: ICVX's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.2yrs | US$6.91m | 2.01% $ 15.7m | |
| Chair of Scientific Advisory Board & Co-Founder | no data | no data | no data | |
| Co-founder & Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Chair | 4.5yrs | US$234.02k | 0.026% $ 204.1k | |
| Independent Director | 2.6yrs | US$184.71k | 0.0056% $ 43.4k | |
| Independent Director | 2.9yrs | US$184.52k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.8yrs | US$196.52k | 0.0057% $ 44.6k |
2.8yrs
Average Tenure
67yo
Average Age
Experienced Board: ICVX's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.